FDA Proposes Changes to Labeling for Over-the-Counter Skin Protectant Astringent Drug Products

Summary

The Food and Drug Administration (FDA) is proposing to update the labeling for over-the-counter (OTC) skin protectant astringent drug products, including revising some existing labels to align with a 2003 rule and adding labels for small packages like styptic pencils, as part of its ongoing review of OTC drug products.